Tetrandrine

Drug Profile

Tetrandrine

Alternative Names: Tranex 18

Latest Information Update: 07 Sep 2009

Price : $50

At a glance

  • Originator Millenia Hope
  • Class Alkaloids; Antiarrhythmics; Antihypertensives; Antimalarials; Antineoplastics; Benzylisoquinolines; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Colorectal cancer; Malaria

Most Recent Events

  • 07 Sep 2009 Discontinued - Preclinical for Malaria in USA (unspecified route)
  • 07 Sep 2009 Discontinued - Phase-III for Colorectal cancer in USA (unspecified route)
  • 11 Feb 2005 Preclinical trials in Malaria in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top